Profile
Mads Buhl Axelsen worked as Director at Aros Pharma ApS, Principal at Novo Nordisk A, Principal at Leo Co. Ltd., Chief Clinical Officer at Azanta Danmark AS, Chief Medical Officer at Neurokey A, and Chief Medical Officer at Gubra A from 2022 to 2026.
Dr. Axelsen earned a doctorate from the University of Copenhagen in 1988.
Former positions of Mads Buhl Axelsen
| Companies | Position | End |
|---|---|---|
| GUBRA A/S | Chief Tech/Sci/R&D Officer | 2026-01-04 |
Neurokey A/S
Neurokey A/S Pharmaceuticals: MajorHealth Technology Develops drugs for the critical care field | Chief Tech/Sci/R&D Officer | 2010-07-29 |
Aros Pharma ApS
Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Develops a therapy for the treatment of gastrointestinal pain | Director/Board Member | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Leo Co. Ltd.
Leo Co. Ltd. Apparel/Footwear RetailRetail Trade Operates a chain of casual clothing stores | Corporate Officer/Principal | - |
Training of Mads Buhl Axelsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Leo Co. Ltd.
Leo Co. Ltd. Apparel/Footwear RetailRetail Trade Operates a chain of casual clothing stores | Retail Trade |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Health Technology |
Neurokey A/S
Neurokey A/S Pharmaceuticals: MajorHealth Technology Develops drugs for the critical care field | Health Technology |
Aros Pharma ApS
Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Develops a therapy for the treatment of gastrointestinal pain | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
- Stock Market
- Insiders
- Mads Buhl Axelsen
















